Showing 1,523 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Access to healthcare

MSF: Untangling the web of antiretroviral price reductions, 17th Edition

Editor's pick
MSF
8 August 2014
Access to healthcare

Even With Obamacare, HIV Patients Are Shouldering A Huge Portion Of Their Treatment Costs

Editor's pick
ThinkProgress
8 August 2014
Pharmaceutical industry

Gilead's Sovaldi soars with sales of $3.48 billion

Editor's pick
Pharma Times
25 July 2014
Hepatitis C treatment

US govt demands more pricing info on Gilead HCV pill

Editor's pick
Pharma Times
15 July 2014
Access to healthcare

Obamacare's Surprising HIV Drug Demand

Editor's pick
Motley Fool
14 July 2014
Pharmaceutical industry

Zombie patents

Editor's pick
The Economist
25 June 2014
New & experimental hepatitis C treatment

HCV drug out of the running

Editor's pick
MedPage Today
23 June 2014
New & experimental hepatitis C treatment

A 4-week hep C cure? Bristol to test drugs with Gilead's Sovaldi

Editor's pick
Reuters
23 June 2014
New & experimental hepatitis C treatment

UNITED STATES: FDA Approves AbbVie's Hepatitis C Regimen for Priority Review

Editor's pick
CDC
19 June 2014
Treatment guidelines

Dolutegravir in HIV-1 infection: Added benefit in adult patients

Editor's pick
Science Daily
19 June 2014
Drug-resistant TB

South Africa: Litigation threat may prompt access to cheaper DR-TB drug

Editor's pick
Health-e
16 June 2014
New & experimental hepatitis C treatment

NICE consults on draft guidance on the drug sofosbuvir (Sovaldi) for treating hepatitis C

Editor's pick
NICE press release
16 June 2014
Pharmaceutical industry

Boehringer gets ‘kite mark’ for health information

Editor's pick
PM Live
13 June 2014
New & experimental HIV treatments

Glaxo's ViiV Joins J&J's Janssen to Develop Single-Pill HIV Drug

Editor's pick
Bloomberg
13 June 2014
Pharmaceutical industry

FDA lifts hold on Achillion's hepatitis C drug, shares jump

Editor's pick
Reuters
11 June 2014
Access to healthcare

Fight the Fakes campaign grows, now includes generics companies

Editor's pick
Intellectual Property Watch
9 June 2014
Access to healthcare

Activists sound alarm on tiered drug prices

Editor's pick
Nature
22 May 2014
New & experimental hepatitis C treatment

OLYSIO™ (simeprevir) receives marketing authorisation in the European Union for the treatment of adults with hepatitis C genotype 1 and 4 infection

Editor's pick
Reuters
16 May 2014
Pharmaceutical industry

Vertex ends hepatitis C investment as sales fall

Editor's pick
CNBC
2 May 2014
Pharmaceutical industry

For Drugs That Save Lives, a Steep Cost

Editor's pick
New York Times
28 April 2014
Pharmaceutical industry

Biotech’s Hard Bargain

Editor's pick
The New Yorker
24 April 2014
Pharmaceutical industry

Gilead Beats Hepatitis C Sales Estimates by $1 Billion

Editor's pick
Bloomberg
23 April 2014
Pharmaceutical industry

Gilead Sciences’ New Drug Applications for Cobicistat and Elvitegravir for HIV Therapy Accepted by U.S. FDA

Editor's pick
Gilead press release
22 April 2014
Access to healthcare

NHS England agrees funding for life-saving hepatitis C drug

Editor's pick
NHS England (press release)
17 April 2014